Abstract: The present invention relates to aqueous silane emulsions based on specific hydrolysable silanes anionic and non-ionic surfactants, a textile comprising a coating obtainable by impregnating the textile with the aqueous silane emulsion according to the present invention and the use of the aqueous silane emulsion according to the present invention for treating textiles. Moreover, the invention also encompasses a method of impregnating a textile with the aqueous silane emulsion according to the present invention as obtained via dilution from a concentrated system.

Abstract: An ambulatory infusion pump can include a guided user help system that allows for a user to correct an error with the pump without needing to summon a home healthcare aide or other medical professional. When an error occurs with the pump, the user can select an option to receive help with the error. The help screen can display a possible solution for correcting the error that the user can follow. Additional help screens can display additional possible solutions if prior possible solution prove ineffective at correcting the problem.

Abstract: An ambulatory infusion pump can include a guided user help system that allows for a user to correct an error with the pump without needing to summon a home healthcare aide or other medical professional. When an error occurs with the pump, the user can select an option to receive help with the error. The help screen can display a possible solution for correcting the error that the user can follow. Additional help screens can display additional possible solutions if prior possible solution prove ineffective at correcting the problem.

Abstract: The invention provides the use of riboflavin in the manufacture of a medicament for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism. The invention also provides a pharmaceutical product for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism, comprising a pharmaceutically effective amount of an anti-hypertensive agent and riboflavin, and the invention further provides a method of treatment of such a subject comprising the administration of riboflavin.

Abstract: A colour display system for aiding the selection and combination of colours in colour scheming is described, wherein the system comprises an array (10) of colour sample elements (12) each of a respective colour, the elements being grouped in discrete blocks (14) according to hue, chromaticity and lightness; the colour sample elements of each block all have colours which are within a hue range respective to that block and which have predetermined chromaticity and lightness properties associated with that block (14); the blocks are arranged in at least 3 parallel lines (16) according to their associated chromaticity and lightness properties such that all of the blocks in each line have similar or the same respective associated chromaticity and lightness properties; each line contains M blocks (where 6?M?12) which are arranged in a hue range sequence along the line; within each block the colour sample elements are arranged in a series of hue increments in the direction of the said lines and corresponding to the

Abstract: The present invention is directed to a photocurable composition for use as an encapsulant, for underfill or attachment adhesives, capable of curing at wavelengths greater than 290 nm. Reaction products of these photocurable compositions have a low level of extractable halide ion, such as less than 100 ppm. In use, the photocurable composition may be applied, for instance, over the wire bonds that electrically connect a semiconductor device to a substrate to maintain a fixed positional relationship and protect the integrity of the electrical connection from vibrational and shock disturbances, as well as from interference from environmental contaminants.